The Unrealised Potential of Digital Therapeutics in the UK

Whilst this may sound like bad news for DTx manufacturers - and, indeed, the NHS and the end users of these powerful tools - it actually points to the vast opportunity that exists for digital therapeutics. Consumers' increasing comfort with technology as a part of their healthcare management is laying the groundwork for DTx success. The question is how to realise that potential. 

In this paper, we illustrate current DTx usage in the UK, using both consumer and doctor research, and highlight some of the barriers to DTx uptake. We also explore the changing regulatory environment and the implications for these tools. Finally, we draw on our market access expertise to suggest five recommendations for achieving patient access to, and successful commercialisation of, digital therapeutics.